Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.
Saved in:
| Title: | Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study. |
|---|---|
| Authors: | Lin ZT; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Gastrointestinal Surgery, Fujian Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China., Wei SM; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China., Wu JY; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China., Zhang ZB; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Wang SJ; Department of Hepato-Biliary-Pancreatic and Vascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province, People's Republic of China., Zhou JY; Department of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian Province, People's Republic of China., Luo MC; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China., Zeng ZX; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Ou XY; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Fu YK; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Li H; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Liu DY; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Wu JY; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China., Yan ML; The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China. |
| Source: | Journal of hepatocellular carcinoma [J Hepatocell Carcinoma] 2024 Sep 24; Vol. 11, pp. 1777-1787. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Country of Publication: New Zealand NLM ID: 101674775 Publication Model: eCollection Cited Medium: Print ISSN: 2253-5969 (Print) Linking ISSN: 22535969 NLM ISO Abbreviation: J Hepatocell Carcinoma Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2253-5969 |
|---|---|
| DOI: | 10.2147/JHC.S477019 |
